Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1198927.RAynQhIBfaBOoeG1OtDosUIpJ71ywAJ8Y4Mvt_9SsAr_c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1198927.RAynQhIBfaBOoeG1OtDosUIpJ71ywAJ8Y4Mvt_9SsAr_c130_assertion type Assertion NP1198927.RAynQhIBfaBOoeG1OtDosUIpJ71ywAJ8Y4Mvt_9SsAr_c130_head.
- NP1198927.RAynQhIBfaBOoeG1OtDosUIpJ71ywAJ8Y4Mvt_9SsAr_c130_assertion description "[Moreover, ErbB signaling (including EGFR, ERBB2, ERBB3, ERBB4 and their downstream genes) is the most extensively mutated pathway, affecting 36.8% (21/57) of the GBC samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1198927.RAynQhIBfaBOoeG1OtDosUIpJ71ywAJ8Y4Mvt_9SsAr_c130_provenance.
- NP1198927.RAynQhIBfaBOoeG1OtDosUIpJ71ywAJ8Y4Mvt_9SsAr_c130_assertion evidence source_evidence_literature NP1198927.RAynQhIBfaBOoeG1OtDosUIpJ71ywAJ8Y4Mvt_9SsAr_c130_provenance.
- NP1198927.RAynQhIBfaBOoeG1OtDosUIpJ71ywAJ8Y4Mvt_9SsAr_c130_assertion SIO_000772 24997986 NP1198927.RAynQhIBfaBOoeG1OtDosUIpJ71ywAJ8Y4Mvt_9SsAr_c130_provenance.
- NP1198927.RAynQhIBfaBOoeG1OtDosUIpJ71ywAJ8Y4Mvt_9SsAr_c130_assertion wasDerivedFrom befree-2016 NP1198927.RAynQhIBfaBOoeG1OtDosUIpJ71ywAJ8Y4Mvt_9SsAr_c130_provenance.
- NP1198927.RAynQhIBfaBOoeG1OtDosUIpJ71ywAJ8Y4Mvt_9SsAr_c130_assertion wasGeneratedBy ECO_0000203 NP1198927.RAynQhIBfaBOoeG1OtDosUIpJ71ywAJ8Y4Mvt_9SsAr_c130_provenance.